Anil K. Sood, M.D.
Director, Blanton-Davis Ovarian Cancer Research Program, Gynecologic Oncology and Reproductive Medicine; Co-Director, Women's Cancer Moonshot Program, Gynecologic Oncology and Reproductive Medicine; Professor, Gynecologic Oncology and Reproductive Medicine; Professor, Cancer Biology; Co-Director, Blanton-Davis Ovarian Cancer Research Program; Director, Ovarian Cancer Research, Department of Gynecologic Oncology; Betty Asche Murray Distinguished Professor in Ovarian Cancer Research; Co-Director, Center for RNA Interference and Non-Coding RNA; Vice Chairman, Gynecologic Oncology and Reproductive Medicine
Dr. Anil K. Sood is Professor and Vice Chair for Translational Research in the Departments of Gynecologic Oncology and Cancer Biology and co-director of the Center for RNA Interference and Non-Coding RNA at the M. D. Anderson Cancer Center. He is also Director of the multi-disciplinary Blanton-Davis Ovarian Cancer Research Program. Dr. Sood co-leads the Women’s Cancer Moonshot Program (focused on ovarian and breast cancers).
Dr. Sood received his medical degree from the University of North Carolina, Chapel Hill, North Carolina. His research is focused in three main areas: 1) mechanisms of angiogenesis and metastasis in ovarian cancer; 2) effects of neuroendocrine stress hormones on ovarian cancer growth and progression, 3) development of new strategies for systemic in vivo siRNA delivery. Dr. Sood has received major recognition for his research accomplishments including the Hunter Award, the Margaret Greenfield/Carmel Cohen Excellence in Ovarian Cancer Research Prize, and the GCF/Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher. Dr. Sood has published over 460 peer-reviewed articles and holds 15 patents related to novel drugs and technologies. He is an elected member of the American Society for Clinical Investigation (ASCI) and an elected fellow of the American Association for the Advancement of Science (AAAS).